Solid Tumors Clinical Trials Database - Free Access to 417 Studies
Access comprehensive clinical trial information for Solid Tumors through Pure Global AI's free database. This collection includes 417 clinical trials across multiple phases including Phase 1, N/A, Early Phase 1. Currently, 68 trials are actively recruiting participants.
Research for Solid Tumors is being conducted in United States of America, China, Japan and 7+ other countries. Leading sponsors include Hoffmann-La Roche and M.D. Anderson Cancer Center. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Study of IBI3005 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Study in Patients With Advanced Solid Tumors to Evaluate the Safety of FTL008.16
JAB-30355 in Patients With Advanced Solid Tumors Harboring TP53 Y220C Mutation
A Study of Adjuvant Atezolizumab or Atezolizumab Plus Tiragolumab in Solid Tumors With Resectable Disease With Intermediate-High Risk of Recurrence and High Tumor Mutational Burden (TMB-H) or Microsatellite Instability (MSI-H)
Spatial Profile of Tumors
A Study of IBI363 in Subjects With Advanced Solid Malignancies
A Study of ZG005 in Patients With Advanced Solid Tumors
QTX3034 in Patients With KRAS G12D Mutation
A Study of Adverse Events, How Intravenously (IV) Infused ABBV-303 Moves Through the Body, and Change in Disease State, as Monotherapy and in Combination With IV Infused Budigalimab (ABBV-181), in Adult Participants With Advanced Solid Tumors
Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
Phase 1 Dose Escalation and Expansion Study of TROP2 CAR Engineered IL15-transduced Cord Blood-derived NK Cells in Patients With Advanced Solid Tumors (TROPIKANA)
A Study of ADRX-0706 in Select Advanced Solid Tumors
Phase 1 Study of IBR854 in Locally Advanced Or Metastatic Solid Tumors
An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors
A Study of XmAb®662 as Monotherapy or in Combination With Pembrolizumab in Advanced Solid Tumors
MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.
A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer
Study of ARTS-021 in Patients With Advanced Solid Tumors
IBI334 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors
Efficacy and Safety Study of F520 Combined With Lenvatinib in the Treatment of Patients With Advanced Solid Tumors
Pure Global AI provides free access to 417 clinical trials studying Solid Tumors, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Hoffmann-La Roche, M.D. Anderson Cancer Center, AstraZeneca, among others.